Clinical Trial Update: Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical thalidomide for chronic graft-versus-host-disease–related stomatitis; the study was terminated and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Stomatitis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: National Institute of Nursing Research (NINR) | Conditions: Graft-versus-Host Disease, Stomatitis | Phase 2 | Status: TERMINATED | Results posted: 2015-11-04